Stockreport

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]

Bolt Biotherapeutics, Inc.  (BOLT) 
PDF This compares to loss of $0.43 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.1 [Read more]